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The Clinical Profile of Moderate Amblyopia 
in Children Younger Than 7 Years 
The Pediatric Eye Disease Investigator Group 
Obiect lve:  To describe the demographic and clinical 
characteristics of a cohort of children with moderate am-
blyopia participating in the Amblyopia Treatment Study 
1, a randomized trial comparing atropine and patching. 
Methods:  The children enrolled were younger than 7 
years and had strabismic, anisometropic, or combined 
strabismic and anisometropic amblyopia. Visual acuity, 
measured with a standardized testing protocol using 
single-surround HOTV optotypes, was 20/40 to 20/100 
in the amblyopic eye, with an intereye acuity difference 
of 3 or more logMAR lines. There were 419 children en-
rolled, 409 of whom met these criteria and were in-
cluded in the analyses. 
proximately 20/60) was similar among the strabismic, an-
isometropic, and combined groups (P= .24), but visual acu-
ity of the sound eyes was worse in the strabismic group com-
pared with the anisometropic group (P<.001). For the 
patients randomized into the patching group, 43% were ini-
tially treated for 6 hours per day, whereas 17% underwent 
full-time patching. Patients with poorer visual acuity in the 
amblyopic eye were prescribed more hours of patching than 
patients with better acuity (P=.003). 
Results: The mean age of the 409 children was 5.3 years. 
The cause of the amblyopia was strabismus in 38%, aniso-
metropia in 37%, and both strabismus and anisometropia 
in 24%. The mean visual acuity of the amblyopic eyes (ap-
Conclusions: In the Amblyopia Treatment Study 1, there 
were nearly equal proportions of patients with strabis-
mic and anisometropic amblyopia. A similar level of vi-
sual impairment was found irrespective of the cause of 
amblyopia. There was considerable variation in treat-
ment practices with regard to the number of hours of ini-
tial patching prescribed. 
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A MBLYOPIA IS the most com-mon cause of visual im-pairment in children. The prevalence of amblyopia in children has been esti-
mated at between 1 % and 4%. 1-4 Most cases 
are associated with eye misalignment, usu-
ally esotropia in infancy or early child-
hood. 5•6 Less frequently, anisometropia 
(difference in refractive error between the 
two eyes) or a combination of strabismus 
and anisometropia are causally associ-
ated with amblyopia. 
The Amblyopia Treatment Study 1 
(ATSl) is a randomized, controlled, single-
masked multicenter clinical trial de-
signed to compare the visual acuity im-
provement achieved using patching 
therapy with adhesive patches with phar-
macological penalization using topical at-
ropine sulfate 1 % drops. Children younger 
than 7 years with moderate amblyopia 
were enrolled at both community-based 
and university-based practices through-
out North America by the Pediatric Eye 
Disease Investigator Group. In this ar-
tide, we describe the demographic and 
clinical characteristics of the cohort of pa-
tients enrolled into the ATSI. 
RESULTS 
Between April 1999 and April 2001, 419 pa-
tients were enrolled at 4 7 sites (10 patients 
were ineligible and were not included in the 
analyses, as indicated in the "Methods" 
section). There were 188 patients enrolled 
at 16 community-based ophthalmology 
practices, 183 patients at 24 departments 
of ophthalmology, and 48 patients at 7 
schools or colleges of optometry. 
See also pages 268 
and387 
The mean± SD age of the 409 patients 
was 5.3± I.I  years, ranging from 2.6 to 6.9 
years. Forty-six percent were girls. The ra-
cial distribution was 83% white, 6% Afri-
can American, 6% Hispanic, 2% Asian, and 
3% mixed or other. Of these patients, 73% 
had received no prior treatment for ambly 
PATIENTS AND METHODS 
The study was supported through a cooperative agree-
ment with the National Eye Institute o f  the National Insti-
tutes of  Health (Bethesda, Md) and conducted at 4 7 clini-
cal sites in North America. Institutional review boards 
approved the protocol and informed consent forms. The 
parent or guardian of  each study patient gave written in-
formed consent. An independent data and safety monitor-
ing committee provided study oversight. 
PATIENT SELECTION 
Eligibility and exclusion criteria for enrollment are listed 
in T a b l e  I . Eligibility testing included the measurement 
of  visual acuity in both eyes using the A TS visual acuity 
testing protocol (see "Measurement of  Visual Acuity"), a 
cycloplegic refraction, an ocular examination, and a sen-
sorimotor evaluation. Procedures were performed accord-
ing to the investigator's usual routine except for the visual 
acuity testing protocol. Visual acuity testing was  per-
formed within the 7 days prior to randomization, whereas 
the remainder of the examination was completed within 2 
months prior to randomization. 
STUDY DEFINITIONS OF AMBLYOPIA 
For each patient, amblyopia was classified as either stra-
b i s m i c ,  r e f r a c t i v e / a n i s o m e t r o p i c ,  o r  c o m b i n e d -
mechanism to indicate the presumptive cause of  ambly-
opia. Strabismic amblyopia was defined as amblyopia (1) 
in  the presence  o f  either a heterotropia a t  distance 
and/or near fixation or a history o f  strabismus surgery 
Table 1. Eligibility and Exclusion Criteria 
Eligibility criteria 
Age <7 y 
Able to measure visual acuity with the Amblyopia Treatment Study 
visual acuity testing protocol, using single-surround H0TV 
optotypes* 
Amblyopia associated with strabismus, refractive 
error/anisometropia, or both†
Visual acuity in the amblyopic eye :520/40 and 220/100 
Visual acuity in the sound eye 220/40 
lntereye acuity difference 2 3  logMAR lines 
No more than 2 mo of amblyopia therapy in the past 2 y (any 
treatment more than 2 y ago was acceptable) 
Refractive error corrected for at least 4 wk‡
Exclusion criteria 
Presence of an ocular cause for reduced visual acuity 
Prior intraocular surgery 
Myopia (spherical equivalent of -0.50 diopters or more) in either 
eye 
Down syndrome 
Known skin reaction to patch or bandage adhesive, or allergy to 
atropine or other cycloplegics 
*Excluded all patients younger than 2 years and many patients younger 
than 3 years. 
†See "Methods" section for definition of each cause. 
‡See "Methods" section for criteria for correction of refractive error. 
(or botulinum toxin injection), and (2) in the absence of 
refractive error meet ing  the  criteria for combined-
mechanism amblyopia. Refractive/anisometropic ambly-
opia (subsequently referred to as anisometropic amb!y-
opia) w a s  def ined a s  amblyopia  in  the  presence  o f  
anisometropia that w a s  0 .50  diopter (D) or more in 
spherical equivalent or a 1.50 D or greater difference in 
astigmatism in any meridian that persisted after at least 
4 weeks of  spectacle correction, with no measurable het-
erotropia  a t  d i s t a n c e  or  n e a r  f ixat ion.  Combined-
mechanism amblyopia was defined as amblyopia in the 
presence of  (1) either a heterotropia at distance and/or 
near fixation or a history of  strabismus surgery (or botu-
linum toxin injection), and (2) anisometropia that was 
1.00 D or more in spherical equivalent or a 1.50 D or 
greater difference in astigmatism in any meridian that 
persisted after at least 4 weeks of  spectacle correction. 
The refractive error criteria for these classifications 
were set arbitrarily based on the consensus opinion of  the 
investigator group. These criteria must be viewed in the 
context o f  a patient diagnosed as having amblyopia who 
has at least a 3-line decrease in visual acuity in the ambly-
opic eye  compared wi th  the sound eye. Some o f  the 
patients classified as having anisometropic amblyopia may 
have had a small deviation o f  8 D or less that was not 
detected during the examination. Different refractive 
criteria were  used in the definitions o f  anisometropic 
amblyopia and combined-mechanism amblyopia, such 
that a patient with 0.50 or 0. 75 D of  spherical anisometro-
pia and strabismus would  b e  classified as strabismic 
rather than combined-mechanism. Small differences in 
refractive error between eyes are common, and in such 
cases the strabismus is likely the primary amblyogenic 
factor. 
opia, 24% had been previously treated with patching, 2% 
had been previously treated with atropine, and 1 % had pre-
viously received some other form of amblyopia therapy. 
The cause of amblyopia was strabismus in 38% of pa-
tients, anisometropia in 3 7%, and both strabismus and an-
isometropia ( combined-mechanism) in 24%. The visual acu-
ity in the amblyopic eye was 20/40 in 11 %, 20/50 in 21 %, 
20/60 in 22%, 20/80 in 23%, and 20/100 in 23% (mean, 
0.53 logMAR units [approximately 20/601). The interocu-
lar acuity difference ranged from 3 to 8 lines with a mean 
of 4.4 lines. There was no difference in mean visual acuity 
of the amblyopic eyes of patients who had received prior 
amblyopia therapy compared with those who had re-
ceived no prior therapy (mean±SD, 0.53±0.13 logMAR 
units for both; P=.68). 
The baseline characteristics of the cohort according 
to cause of amblyopia are summarized in T a b l e  2 .  The 
patients with strabismic amblyopia were slightly younger 
at enrollment (mean age, 5.1 years) than the patients with 
anisometropic or combined-mechanism amblyopia (mean 
age, 5.4 years and 5.2 years, respectively; P= .04 ). Mean vi-
sual acuity in the amblyopic eye was similar for all 3 causes 
ofamblyopia (P=.24), but acuity in thesoundeyewasworse 
with strabismic amblyopia and best with pure anisome-
tropic amblyopia even after adjusting for age, refractive er-
CORRECTION OF REFRACTIVE ERROR 
For patients with strabismic amblyopia, refractive error was 
corrected according to the investigator's usual routine. Pa-
tients with anisometropic or combined-mechanism ambly-
opia were required to wear their current spectacle correc-
tion for at least 4 weeks when there was anisometropia of 1.00 
D or more in spherical equivalent or a 1.50 D or greater me-
ridional difference subject to the following guidelines: (1) full 
correction of anisometropia; (2) hy p eropia of more than 3 
D corrected by either prescribing the maximum-tolerated hy-
peropic correction or reducing the cycloplegic refraction by 
up to +1.50 D; and (3) correction of astigmatism in either 
eye of 1.50 D or greater (full correction of astigmatism 
preferred). If a patient was already wearing glasses, a new pre-
scription was not necessary as long as (1) both the spherical 
equivalent and cylinder were within 0.50 D of fully correct-
ing the anisometropia, and (2) the cylinder axis in both eyes 
was within 10° of the axis in the spectacles when the cylin-
der power was 1.00 Dor greater (if cylinder power w a s <  1.00 
D, a spectacle change was at the investigator's discretion). 
MEASUREMENT OF VISUAL ACUITY 
Visual acuity was measured in both eyes using the ATS vi-
sual acuity testing protocoF administered by a study-
certified vision tester. The testing protocol consists of the pre-
sentation of single-surround HOTV optotypes on the Baylor 
Video Acuity Tester (Medtronic Xomed Solan Ophthalmics, 
Jacksonville, Fla) in 4 steps: a screening phase, followed by 
a first-threshold determination (phase 1), reinforcement phase, 
and second-threshold determination (phase 2). In the screen-
ing phase, starting from 20/100, a single letter at each log-
MAR size is shown until one is missed. In phase 1, letters are 
ror in the sound eye, and prior treatment of amblyopia 
(P<.001). This resulted in a smaller interocular acuity dif-
ference with strabismic amblyopia than with the other 2 
causes (P<.001). Refractive error data for the 3 causes dif-
fered, consistent with the definitions for each cause. The 
magnitude of the anisometropia was greater when the am-
blyopia was due to anisometropia alone than when due to 
anisometropia combined with strabismus (P= .02). Among 
the patients with anisometropia, visual acuity in the am-
blyopic eye was worse when anisometropia was 3.00 Dor 
more than when it was less than 3.00 D (mean visual acu-
ity, 0 .5 7 logMAR units I approximately 20/80 I and 0. 48 log-
MAR units [approximately 20/60], respectively; P<.001). 
The baseline characteristics according to age at en-
rollment are listed in Table 3 .  Mean visual acuity in both 
the amblyopic and sound eyes was worse in the younger 
children (P=.005 and P<.001, respectively), but the in-
tereye acuity difference did not vary with age (P=.59). 
The mean refractive errors of the amblyopic and sound 
eyes, as well as the anisometropia, varied little with age. 
For patients randomized into the patching group, the 
initial number of daily patching hours was at the discre-
tion of the investigator, with a minimum of 6 hours. Six 
or 8 hours per day were prescribed for 73% of the 212 pa-
tients, whereas 10 or more hours were prescribed for 27%. 
shown starting 2 logMAR levels above the missed level in the 
screening phase to determine the smallest level at which 3 
of 3 or 3 of 4 letters are correctly identified. In the reinforce-
ment phase, to get the child with drifting attention back on 
track, 3 larger letters are shown starting 2 levels above the 
lowest correct level in phase 1. In phase 2, the child is re-
tested at the last level missed in phase l ;  if3 of3 or 3 of 4 are 
correctly identified, the test continues at the next-smallest level 
until a level is failed. The visual acuity score is the lowest level 
at which 3 of 3 or 3 of 4 presentations are correctly identi-
fied in phase 1 or phase 2. 
DATA ANALYSIS 
Ten patients enrolled in the study did not meet the eligi-
bility criteria and were not included in the analyses (5 pa-
tients did not have a definable cause for amblyopia, 1 had 
a visual acuity in the amblyopic eye of 20/30, 1 had an acu-
ity in the amblyopic eye of 20/125, and 3 had an interocu-
lar difference of only 2 logMAR lines). 
Differences in baseline characteristics among sub-
groups based on cause of amblyopia and age at enrollment
were assessed, as indicated, with x2 tests as well as analy-
sis of variance and analysis of covariance ( with t tests used 
for subsequent 2-subgroup comparisons). The associa-
tion between prior treatment for amblyopia and ambly-
opic eye visual acuity was assessed using a t test. The as-
sociations between the number of hours of daily patching 
prescribed at enrollment and visual acuity in the ambly-
opic eye, age at enrollment, practice type (community vs 
institution), and physician ty p e (ophthalmologist vs op-
tometrist) were evaluated with Kruskal-Wallis tests. Sta-
tistical analyses were performed using SAS statistical soft-
ware (PC version 8.01; SAS Institute Inc, Cary, NC). 
Although the number of hours prescribed had no consis-
tent relationship to age (P= .50), it was related to the am-
blyopic eye acuity (P= .003). Among the 19 patients with 
an amblyopic eye acuity of 20/40, all were prescribed 6 or 
8 hours per day of patching, whereas among the 49 pa-
tients with 20/100 amblyopic eye acuity, only 53% were 
prescribed 6 or 8 hours of patching per day. In contrast, 
full-time patching was prescribed for no patients with 20/40 
amblyopic eye acuity and for 22% of patients with 20/100 
acuity (Table 4) .  There was no difference in the number 
of patching hours prescribed by university-based investi-
gators compared with community-based investigators 
(P=.36). However, on average the optometrist investiga-
tors prescribed fewer hours of patching than the ophthal-
mologist investigators (P= .01); only 4% of patients en-
rolled by an optometrist were initially prescribed 10 or more 
hours of patching per day, compared with 31 % of pa-
tients enrolled by an ophthalmologist. 
The ATS 1 was conducted using a simple protocol to com-
pare the effectiveness of patching and topical atropine 1 % 
solution as treatments for moderate amblyopia in chil-
dren younger than 7 years. The study group investigators 
Table 2. Baseline Characteristics According to Cause of Amblyopia* 
Cause of Amblyopia 
Overall P † 
Total Strabismus Anisometropia Combined Unadjusted 
2-Group Comparisons, P‡
Strabismus vs Strabismus Anisometropia 
(N = 409) (n = 156) (n = 153) (n = 100) (Adjusted for Age) Anisometropia vs Combined vs Combined 
Age, y 
< 3  7 (2) 2 (1) 3 (2) 2 (2) 
3to < 4  60(15) 33 (21) 13 (9) 14 (14) 
4to < 5  83 (20) 30 (19) 31 (20) 22 (22) 
5to < 6  135 (33) 40 (26) 56 (37) 39 (39) 
6to < 7  124 (30) 51 (33) 50 (33) 23 (23) 
Mean (SD), logMAR units 5.3 (1.1) 5.1 (1.2) 5.4 (1.0) 5.2(1.0) .04 .02 .76 .06 
Visual acuity (amblyopic eye) 
20/100 95 (23) 28 (18) 35 (23) 32 (32) 
20/80 95 (23) 44 (28) 31 (20) 20 (20) 
20/60 91 (22) 35 (22) 36 (24) 20 (20) 
20/50 84(21) 32 (21) 33 (22) 19 (19) 
20/40 44(11) 17 (11) 18 (12) 9 (9) 
Mean (SD), logMAR units 0.53 (0.13) 0.52 (0.13) 0.52 (0.13) 0.55 (0.14) .24 .95 .13 .13 
(.27) 
Visual acuity (sound eye) 
20/40 38 (9) 24 (15) 6 (4) 8 (8) 
20/30 81 (20) 38 (24) 21 (14) 22 (22) 
20/25 113 (28) 57 (37) 30 (20) 26 (26) 
20/20 148(36) 36 (23) 75 (49) 37 (37) 
20/15 29 (7) 1 (0.6) 21 (14) 7 (7) 
Mean (SD), logMAR units 0.09 (0.11) 0.13 (0.10) 0.05 (0.10) 0.09 (0.11) <.001 <.001 .001 .002 
(<.001) 
lntereye difference, lines 
3 128 (31) 66 (42) 37 (24) 25 (25) 
4 117 (29) 56 (36) 37 (24) 24 (24) 
5 78 (19) 20 (13) 33 (22) 25 (25) 
6 51 (12) 10 (6) 22 (14) 19 (19) 
7 30 (7) 4 (3) 20 (13) 6 (6) 
8 5 (1) 0 4 (3) 1 (1) 
Mean (SD), lines 4.4 (1.3) 3.9 (1.0) 4.8 (1.4) 4.6 (1.3) <.001 <.001 <.001 .37 
(<.001) 
Refractive error (amblyopic eye), D§ 
19(5) 14 (9) 4 (3) 1 (1) 
33 (8) 23 (15) 9 (6) 1 (1) 
37 (9) 21 (13) 10 (7) 6 (6) 
60 (15) 27 (17) 25 (16) 8 (8) 
260 (64) 71 (46) 105 (69) 84 (84) 
<1.00 
1.00 to <2.00 
2.00 to <3.00 
3.00 to <4.00 
≥4,00 
Mean (SD), logMAR units 4.52 (2.09) 3.80 (2.18) 4.70 (1.98) 5.37 (1.72) <.001 .002 <.001 .006 
(<.001) 
Refractive error (sound eye), D§ 
67 (16) 13 (8) 42 (27) 12 (12) 
99 (24) 27 (17) 56 (37) 16 (16) 
71 (17) 25 (16) 25 (16) 21 (21) 
61 (15) 25 (16) 12 (8) 24 (24) 
111 (27) 66 (42) 18 (12) 27 (27) 
<1.00 
1.00 to <2.00 
2.00 to <3.00 
3.00 to <4.00 
≥4,00 
Mean (SD), logMAR units 2.83 (2.01) 3.54 (2.08) 1.95 (1.67) 3.05 (1.91) <.001 <.001 .06 <.001 
(<.001) 
Anisometropia, D§ 
<0.50 110 (27) 98 (63) 8 (5) 4 (4) 
0.50 to <1.00 69 (16) 58 (37) 10 (7) 1 (1) 
1.00 to <2.00 65 (16) 22 (14) 43 (43) 
2.00 to <3.00 70 (17) 43 (28) 27 (27) 
3.00 to <4.00 51 (12) 39 (25) 12 (12) 
44 (11) 31 (20) 13 (13) ≥4,00 
Mean (SD), logMAR units 1.73 (1.62) 0.30 (0.30) 2.79 (1.52) 2.33 (1.36) <.001 .02 
(<.001) 
*Data are presented as number (percentage) unless otherwise indicated. D indicates diopters; ellipses, not applicable. 
†Unadjusted Pvalues from analysis of variance; adjusted Pvalues from analysis of covariance were adjusted tor age as a continuous variable. 
‡Unadjusted Pvalues from ttest. 
§Expressed as spherical equivalent. 
Table 3. Baseline Characteristics According to Age at Enrollment* 
Age,y 
P† 
< 4  4to < 5  5to < 6  6to < 7  Unadjusted 
(n = 67) (n = 83) (n = 135) (n = 124) (Adjusted for Cause) 
Cause of amblyopia 
Strabismus 35 (52) 30 (36) 40 (30) 51 (41) 
Anisometropia 16 (24) 31 (37) 56 (41) 50 (40) .03 
Combined-mechanism 16 (24) 22 (27) 39 (29) 23 (19) 
Visual acuity (amblyopic eye) 
20/100 27 (40) 18 (22) 27 (20) 23 (19) 
20/80 17 (25) 22 (27) 34 (25) 22 (18) 
20/60 10 (15) 20 (24) 30 (22) 31 (25) 
20/50 5 (7) 15 (18) 31 (23) 33 (27) 
20/40 8 (12) 8 (10) 13 (10) 15 (12) 
Mean (SD), logMAR units 0.57 (0.14) 0.53 (0.13) 0.52 (0.13) 0.50 (0.13) .005 
(.002) 
Visual acuity, (sound eye) 
20/40 19 (28) 4 (5) 7 (5) 8 (6) 
20/30 14 (21) 25 (30) 32 (24) 10 (8) 
20/25 12 (18) 27 (33) 38 (28) 36 (29) 
20/20 21 (31) 23 (28) 50 (37) 54 (44) 
20/15 1 (1) 4 (5) 8 (6) 16 (13) 
Mean (SD), logMAR units 0.14 (0.12) 0.10 (0.10) 0.09 (0.10) 0.05 (0.10) <.001 
(<.001) 
lntereye difference, lines 
3 22 (33) 27 (33) 44 (33) 35 (28) 
4 23 (34) 26 (31) 34 (25) 34 (27) 
5 7 (10) 15 (18) 31 (23) 25 (20) 
6 9 (13) 9 (11) 15 (11) 18 (15) 
7 6 (9) 5 (6) 10 (7) 9 (7) 
8 0 1 (1) 1 (0.7) 3 (2) 
4.3 (1.3) 4.3 (1.3) 4.4 (1.3) 4.5 (1.4) .59 
(.18) 
Mean (SD) 
Refractive error (amblyopic eye), D‡ 
1 (1) 3 (4) 3 (2) 12 (10) 
3 (4) 6 (7) 6 (4) 18 (15) 
7 (10) 11 (13) 12 (9) 7 (6) 
9 (13) 16 (19) 22 (16) 13 (10) 
47 (70) 47 (57) 92 (68) 74 (60) 
<1.00 
1.00 to <2.00 
2.00 to <3.00 
3.00 to <4.00 
≥4.00 
Mean (SD), logMAR units 4.75 (1.75) 4.38 (2.17) 4.78 (1.94) 4.21 (2.33) .11 
(.06) 
Refractive error (sound eye), D‡ 
6 (9) 12 (14) 22 (16) 27 (22) 
13 (19) 19 (23) 34 (25) 33 (27) 
10 (15) 16 (19) 22 (16) 23 (19) 
16 (24) 13 (16) 24 (18) 8 (6) 
22 (33) 23 (28) 33 (24) 33 (27) 
<1.00 
1.00 to <2.00 
2.00 to <3.00 
3.00 to <4.00 
≥4.00 
Mean (SD), logMAR units 3.27 (1.72) 2.88 (2.08) 2.80 (2.08) 2.58 (2.03) .16 
(.07) 
Anisometropia, D‡ 
<0.50 18 (27) 26 (31) 27 (20) 39 (31) 
0.50to <1.00 19 (28) 10 (12) 20 (15) 20 (16) 
1.00 to <2.00 7 (10) 15 (18) 27 (20) 16 (13) 
2.00 to <3.00 11 (16) 17 (20) 26 (19) 16 (13) 
3.00 to <4.00 6 (9) 10 (12) 15 (11) 20 (16) 
6 (9) 5 (6) 20 (15) 13 (10) ≥4.00 
Mean (SD), logMAR units 1.49 (1.51) 1.53 (1.48) 2.01 (1.74) 1.68 (1.61) .07 
(.96) 
*Data are presented as number (percentage) unless otherwise indicated. D indicates diopters. 
†Unadjusted Pvalue for association between cause of amblyopia and age from x 2 test. All other unadjusted Pvalues were determined using analysis of 
variance; adjusted Pvalues from analysis of covariance were adjusted for cause of amblyopia. 
‡Expressed as spherical equivalent. 
included pediatric ophthalmologists and optometrists from 
both university and community-based practices. The study 
was designed to approximate clinical practice as much as 
possible, with the exceptions being the use of randomiza-
tion to determine the treatment prescribed for each pa-
tient and the use of a standardized single-surround HOTV 
Table 4. Number of Hours of Daily Patching Prescribed at Enrollment for Patients in the Patching Group 
According to Baseline Visual Acuity in the Amblyopic Eye* 
Hours of 
Grouped by Visual Acuity in the Amblyopic Eye 
Patching All Patients 20/40 20/50 20/60 20/80 
N =212 n = 19 n = 46 n = 56 n = 42 n = 49 
6 92 (43) 12 (63) 22 (48) 27 (48) 19 (45) 12 (24) 
8 62 (29) 7 (37) 15 (33) 19 (34) 7 (17) 14 (29) 
10 15 (7) 0 1 (2) 0 4 (10) 10 (20) 
12 7 (3) 0 1 (2) 2 (4) 2 (5) 2 (4) 
Full-time 36 (17) 0 7 (15) 8 (14) 10 (24) 11 (22) 
*Data are presented as number (percentage). The number of patching hours was prescribed according to investigator discretion (with a minimum of 6 hours 
per day); full-time was defined as all or all but 1 waking hours. P = .003 for association between hours of patching and amblyopic eye visual acuity from the 
Kruskal-Wallis test. 
optotype visual acuity testing protocol, which we devel-
oped specifically for this study. 7 
The clinical profile of the cohort must be viewed in 
the context of the eligibility and exclusion criteria for the 
study (Table 1). The eligibility criteria for enrollment were 
broad, with the intention to include most children with 
amblyopia younger than 7 years who were developmen-
tally able to perform single-surround HOTV optotype vi-
sual acuity testing. This effectively set a lower age limit 
of about 3 years, although 7 children between the ages 
of 2.5 and 3 years successfully completed visual acuity 
testing and were enrolled. To avoid including prior treat-
ment failures in the study, children who had received more 
than 2 months of amblyopia treatment in the prior 2 years 
were not enrolled. The visual acuity limit for the ambly-
opic eye was set at 20/100 because atropine is not thought 
to be an effective treatment for worse acuities. 8•9 Eligi-
bility required a 3-line difference in visual acuity be-
tween eyes (1) to assure that a true reduction in acuity 
was present (a reliability study using our acuity testing 
protocol found that a 3-line interocular difference was 
required for reasonable certainty that amblyopia was pres-
ent7), and (2) to have a sufficient depth of amblyopia to 
assess improvement with treatment. 
Our cohort's mean age of 5.3 years and the equal 
sex distribution are consistent with several previous re-
ports describing populations with amblyopia. 5•6 •1 0•1 1 Our 
cohort was 83% white, with small percentages of Afri-
can American, Hispanic, and Asian patients. This racial 
distribution likely reflects the nature of the investiga-
tors' clinical practices. Because our study is not popula-
tion based, our data should not be used to suggest any 
demographic variation in the prevalence of amblyopia be-
tween ethnic or racial groups. 
Our cohort had approximately equal proportions of 
patients with amblyopia due to strabismus and anisome-
tropia, with about a quarter of the patients having ele-
ments of both. The mean ages at enrollment for these 
groups of children were 5.1, 5.4, and 5.2 years, respec-
tively. These data differ somewhat from those in the popu-
lation-based study by Woodruff et al6 of 961 children with 
amblyopia in the United Kingdom. The authors found the 
cause to be strabismus in 57%, anisometropia in 17%, and 
a combination of the two in 27% of patients. The mean 
ages of children with strabismic, anisometropic, and com-
bination amblyopia were 3.3, 5.6, and 4.4 years, respec-
tively. Our data also differ from those of Shaw et al,5 who 
reported that in 1531 children with amblyopia in the United 
Kingdom, strabismus was the cause in 45%, anisometro-
pia in 17%, a combination of the two in 35%, and depri-
vation due to cataract or corneal scarring in 3%. In the study 
by Shaw and colleagues, the median ages of children with 
strabismic, anisometropic, and combination amblyopia 
were 3.6, 6.3, and 4. 7 years, respectively. 
The 2 studies from the United Kingdom differ from 
ours in 4 important ways. First, extensive prior treat-
ment was an exclusion in our study. This criterion would 
reduce the proportion of patients diagnosed (and pre-
sumably treated) at younger ages entering the ATSl. These 
younger patients would more often have strabismus, as 
seen in the 2 studies from the United Kingdom. 5•6 The 
second difference was our requirement for the children 
to complete a single-surround HOTV optotype visual acu-
ity testing protocol. This reduced the proportion of pa-
tients with strabismus in our cohort by excluding most 
children with amblyopia younger than 3 years. The third 
difference was our exclusion of deep amblyopia, also more 
frequently associated with strabismus. 1 2•1 3 Finally, the stud-
ies from the United Kingdom defined anisometropia as 
at least 1 D, compared with the 0.5-D minimum used in 
the ATSl. However, this creates only a small difference 
between studies; our cohort included just 18 patients with 
anisometropia of less than 1 D, and 12 of the 18 had a 
difference in astigmatism between eyes of+ 1.50 Dor more. 
We found that the visual acuity of the amblyopic eyes 
was similar whether the amblyopia was caused by strabis-
mus, anisometropia, or both conditions. Rodier et al14 also 
found no difference in initial acuity among their patients 
with these 3 types of amblyopia. Although previous stud-
ies have suggested that strabismic and combined-mech-
anism amblyopia represent a more severe physiological defi-
cit, due to active cortical suppression, than purely 
anisometropic amblyopia,2.1 5 ,1 6 the restriction of our co-
hort to children with an amblyopic eye acuity of 20/100 
or better limits our ability to address this issue. 
As expected, visual acuity in the sound eye was 
slightly better with older age. This phenomenon may re-
flect the child's increasing sophistication with testing and 
optotypes at older ages. 17 For this reason, the interocu-
lar difference in acuity should be a useful measure to ac-
count for this age effect on acuity testing. However, for 
assessing change in visual acuity with treatment during 
20/100 
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a several-month period (in which the age effect is ex-
pected to be minimal), the change in interocular acuity 
difference may be less useful than the change in ambly-
opic eye acuity alone; the former is affected by the test-
ing variability in both eyes, whereas the latter is affected 
by the variability in only one eye. 7•1 8 
We were surprised by the variation in visual acuity 
of the sound eye according to cause of amblyopia, which 
persisted even after statistically adjusting for age, refrac-
tive error in the sound eye, and prior treatment for am-
blyopia. We do not have a simple explanation for why 
sound eye acuity would be best in patients with aniso-
metropia, worst in patients with strabismus, and inter-
mediate in patients with both anisometropia and stra-
bismus. Levi and Klein19 previously reported a similar 
finding for Vernier acuity. They noted that the sound eyes 
of patients with strabismus had poorer visual acuity than 
those of patients with anisometropia. The authors sug-
gested that strabismus may produce cortical deficits in 
the sound eye due to abnormal binocular interactions. 
Patching therapy has been the mainstay of ambly-
opia treatment in North America despite the lack of mean-
ingful data demonstrating its superiority compared with 
other modalities. 2 0•2 1 In planning this study, when we sur-
veyed the Pediatric Eye Disease Investigator Group about 
their treatment practices for moderate amblyopia, we 
found that very few prescribed atropine as a primary treat-
ment modality; when patching was prescribed, the in-
tensity of treatment varied widely, from a few hours a 
day to all waking hours. Our study data support the sur-
vey results. The small number of study patients who had 
been previously treated with atropine compared with the 
number previously treated with patching is suggestive 
of the investigators' limited use of atropine as a treat-
ment for amblyopia prior to this study. The number of 
patching hours prescribed at enrollment for the patch-
ing group varied from the allowable minimum of 6 hours 
per day, prescribed for 43%, to full-time patching, pre-
scribed for 17%. The number of patching hours was re-
lated to the severity of the amblyopia but not to the age 
of the patient or to whether the investigator was institu-
tionally or community based. The optometrist investi-
gators tended to prescribe fewer hours of initial patch-
ing than the ophthalmologist investigators. 
In summary, we describe the clinical profile of a large 
cohort of children younger than 7 years with moderate stra-
bismic and anisometropic amblyopia. There was a nearly 
equal distribution of cause between strabismus and an-
isometropia (38%), with about 25% of patients having char-
acteristics of both conditions. Although visual acuity in 
the amblyopic eye did not differ according to cause of am-
blyopia, acuity in the sound eye was worse with strabis-
mic amblyopia than with anisometropic amblyopia. There 
was considerable variation in treatment practices with re-
gard to the number of hours of initial patching pre-
scribed by the investigators. However, we did find that the 
number of patching hours was positively related to the 
depth of the amblyopia and was greater for ophthalmolo-
gists than for optometrists. The data reported in this ar-
ticle define the clinical profile of the patients enrolled in 
the ATSl. These data will be useful for interpreting the 
results of the randomized trial comparing patching with 
atropine as treatments for moderate amblyopia. 
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